Abstract
Agonist triggering combined with oocyte vitrification and ET in a subsequent natural cycle avoids ovarian hyperstimulation syndrome in patients at risk and shows excellent cycle outcome.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have